Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Patient perspectives on breast cancer treatment plan and summary documents in community oncology care: A pilot program
    Journal Article

    Blinder, V. S.; Norris, V. W.; Peacock, N. W.; Griggs, J. J.; Harrington, D. P.; Moore, A.; Theriault, R. L.; Partridge, A. H.
    Cancer (2013)

    Fulltext@MSK | Save
  • Integration of cell line and clinical trial genome-wide analyses supports a polygenic architecture of paclitaxel-induced sensory peripheral neuropathy
    Journal Article

    Wheeler, H. E.; Gamazon, E. R.; Wing, C.; Njiaju, U. O.; Njoku, C.; Baldwin, R. M.; Owzar, K.; Jiang, C.; Watson, D.; Shterev, I.; more...
    Clinical Cancer Research (2013)

    Fulltext@MSK | Save
  • Time to adjuvant chemotherapy for breast cancer in national comprehensive cancer network institutions
    Journal Article

    Vandergrift, J. L.; Niland, J. C.; Theriault, R. L.; Edge, S. B.; Wong, Y. N.; Loftus, L. S.; Breslin, T. M.; Hudis, C. A.; Javid, S. H.; Rugo, H. S.; more...
    JNCI: Journal of the National Cancer Institute (2013)

    Fulltext@MSK | Save
  • Hepatic arterial infusion and systemic chemotherapy for breast cancer liver metastases
    Journal Article

    Ang, C.; Jhaveri, K.; Patel, D.; Gewirtz, A.; Seidman, A.; Kemeny, N.
    Breast Journal (2013)

    Fulltext@MSK | Save
  • Norton-Simon hypothesis
    Book Section

    Morris, P. G.; Gilewski, T. A.; Norton, L.
    In Perry, M. C. (Eds.) Perry's The Chemotherapy Source Book. 5th ed (2012)

    Fulltext@MSK | Save
  • Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with HER2-overexpressing metastatic breast cancer (MBC)
    Meeting Abstract

    Datko, F. M.; D'Andrea, G.; Dickler, M. N.; Theodoulou, M.; Goldfarb, S. B.; Lake, D.; Fornier, M. N.; Modi, S.; Sklarin, N. T.; Comen, E. A.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • IBL2001: Phase (ph) I/II study of a novel dose-dense (dd) schedule of indibulin for the treatment of metastastic breast cancer
    Meeting Abstract

    Traina, T. A.; Hudis, C.; Gonzalez, J.; Anthony, S. P.; Smith, D. A.; Chandler, J. C.; Jac, J.; Youssoufian, H.; Norton, L.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A phase II, single-arm, feasibility study of dose-dense doxorubicin and cyclophosphamide (AC) followed by eribulin mesylate for the adjuvant treatment of early-stage breast cancer (EBC)
    Meeting Abstract

    Traina, T. A.; Hudis, C.; Lehman, R.; Rege, J.; Wang, W.; Cox, D.; Seidman, A. D.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Final results of phase I/II trial of vorinostat in combination with cyclophosphamide, etoposide, prednisone, and rituximab (R-CVEP) for elderly patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL)
    Meeting Abstract

    Straus, D. J.; Hamlin, P. A.; Matasar, M. J.; Palomba, M. L.; Drullinsky, P.; Zelenetz, A. D.; Gerecitano, J. F.; Noy, A.; Hamilton, A. M.; Wegner, B.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Colorectal cancer survivors' needs and preferences for survivorship information
    Meeting Abstract

    Salz, T.; McCabe, M. S.; Blinder, V. S.; Elkin, E. B.; Kemeny, M.; Saltz, L.; Temple, L. K. F.; Oeffinger, K. C.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save